VanEck Vectors Pharmaceutical ETF [PPH] Stock Forecast

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on 12/20/2011.

VanEck Pharmaceutical ETF has had the strongest one-year performance of four major pharmaceutical ETF competitors due to its unique mix of Novo Nordisk, Eli Lilly, and Johnson & Johnson. Eli Lilly, PPH's top holding, saw a 28% increase in Q2 revenue from its Mounjaro injection, a treatment for Type 2 diabetes. Recent medical treatments such as Ozempic and Wegovy are expected to drive $3.3 billion and $1.1 billion, respectively in revenue for Novo Nordisk in Q3 2023, PPH's second-largest holding.

Eli Lilly is a mega-cap stock in the Health Care sector that has performed well in 2023, and it's the top holding in the VanEck Pharmaceutical ETF. I have a buy rating on the low-cost and style & geographically-diverse ETF. PPH offers a higher income compared to owning an S&P 500 index fund, but it carries technical risks and, but is top-heavy.

According to the latest CDC National Diabetes Statistics Report, more than 37 million people have diabetes in the U.S., or 11.3% of the population. The statistics for obesity are also dismal, as the World Health Organization reports the global obesity count at more than 1 billion.

Ozempic commercials are, at this point, ubiquitous and while that's an anecdotal example, it also represents confirmation that obesity drugs are the next big thing in the pharmaceuticals industry.

The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.

Wall Street delivered a mixed performance last week.

Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.

Value-focused investing comes to rescue if high-growth sectors fail for some reasons.

VanEck Vectors Pharmaceutical ETF is a US stock and trading under the symbol PPH

VanEck Vectors Pharmaceutical ETF stock price is $78.4347 today.

Yes, VanEck Vectors Pharmaceutical ETF is a publicly traded company.